Marlynn Giles Stovall, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 451 Highway 13 S, Waverly, TN 37185 Phone: 931-290-0241 Fax: 931-296-1353 |
News Archive
Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy. Completed in a large-scale EU project, the lead author of the review article is Professor Ilkka Harvima of the University of Eastern Finland and Kuopio University Hospital.
"Some governors, frustrated by halted federal efforts to overhaul the U.S. health-care system" and by lingering budget shortfalls deepened by rising health costs, "are introducing their own changes at the state level," The Wall Street Journal reports. While some states, such as Massachusetts, have already taken on health care, others, such as Colorado, Pennsylvania and Republican-led Utah, are now tackling the issues, including cost. "Some governors suggested they may be better equipped to work with one another on health care than congressional leaders who have been at an impasse over federal legislation" (Thiruvengadam, 2/22).
At its annual cancer symposium, the Society of Surgical Oncology will present the 43rd annual James Ewing Layman's Award to Kimberly T. Duchossois of Barrington Hills, Ill., for her deep commitment and long-term efforts to improve the quality of cancer treatment and help cancer patients get the information they need to make wise decisions about their care.
Soligenix, Inc., a development stage biopharmaceutical company, announced today that its program for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the induction treatment of mild-to-moderate pediatric Crohn's disease has received "Fast Track" designation from the U.S. Food and Drug Administration (FDA).
› Verified 1 days ago